Lo, Chi-WenChi-WenLoLi, Wei-MingWei-MingLiKe, Hung-LungHung-LungKeChang, Yi-HueiYi-HueiChangWu, Hsi-ChinHsi-ChinWuChen, I-Hsuan AlanI-Hsuan AlanChenLin, Jen-TaiJen-TaiLinCHAO-YUAN HUANGCHUNG-HSIN CHENTseng, Jen-ShuJen-ShuTsengLin, Wun-RongWun-RongLinJiang, Yuan-HongYuan-HongJiangLee, Yu-KhunYu-KhunLeeTsai, Chung-YouChung-YouTsaiChung, Shiu-DongShiu-DongChungHsueh, Thomas YThomas YHsuehChiu, Allen WAllen WChiuJou, Yeong-ChinYeong-ChinJouCheong, Ian-SengIan-SengCheongChen, Yung-TaiYung-TaiChenChen, Jih-ShengJih-ShengChenChiang, Bing-JuinBing-JuinChiangYu, Chih-ChinChih-ChinYuLin, Wei YuWei YuLinWu, Chia-ChangChia-ChangWuChen, Chuan-ShuChuan-ShuChenWeng, Han-YuHan-YuWengTsai, Yao-ChouYao-ChouTsai2023-02-172023-02-1720222234-943Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/628308The advantage of adjuvant chemotherapy for upper urinary tract urothelial cancer (UTUC) has been reported, whereas its impact on upper tract cancer with variant histology remains unclear. We aimed to answer the abovementioned question with our real-world data.enUTUC; adjuvant chemotherapy; nephroureterectomy; upper urinary tract urothelial cancer; variant histology[SDGs]SDG3journal article10.3389/fonc.2022.843715355303352-s2.0-85129581873WOS:000876147700001https://api.elsevier.com/content/abstract/scopus_id/85129581873